» Articles » PMID: 20368138

Combination of 16S RRNA Variable Regions Provides a Detailed Analysis of Bacterial Community Dynamics in the Lungs of Cystic Fibrosis Patients

Overview
Journal Hum Genomics
Publisher Biomed Central
Specialty Genetics
Date 2010 Apr 7
PMID 20368138
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic bronchopulmonary bacterial infections remain the most common cause of morbidity and mortality among patients with cystic fibrosis (CF). Recent community sequencing work has now shown that the bacterial community in the CF lung is polymicrobial. Identifying bacteria in the CF lung through sequencing can be costly and is not practical for many laboratories. Molecular techniques such as terminal restriction fragment length polymorphism or amplicon length heterogeneity-polymerase chain reaction (LH-PCR) can provide many laboratories with the ability to study CF bacterial communities without costly sequencing. The aim of this study was to determine if the use of LH-PCR with multiple hypervariable regions of the 16S rRNA gene could be used to identify organisms found in sputum DNA. This work also determined if LH-PCR could be used to observe the dynamics of lung infections over a period of time. Nineteen samples were analysed with the V1 and the V1_V2 region of the 16S rRNA gene. Based on the amplicon size present in the V1_V2 region, Pseudomonas aeruginosa was confirmed to be in all 19 samples obtained from the patients. The V1 region provided a higher power of discrimination between bacterial profiles of patients. Both regions were able to identify trends in the bacterial population over a period of time. LH profiles showed that the CF lung community is dynamic and that changes in the community may in part be driven by the patient's antibiotic treatment. LH-PCR is a tool that is well suited for studying bacterial communities and their dynamics.

Citing Articles

Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease.

Cai L, Gao P, Wang Z, Dai C, Ning Y, Ilkit M Front Immunol. 2022; 13:988708.

PMID: 36032147 PMC: 9411651. DOI: 10.3389/fimmu.2022.988708.


The role of the bacterial microbiome in lung disease.

Dickson R, Erb-Downward J, Huffnagle G Expert Rev Respir Med. 2013; 7(3):245-57.

PMID: 23734647 PMC: 4007100. DOI: 10.1586/ers.13.24.


The microbiome of the lung.

Beck J, Young V, Huffnagle G Transl Res. 2012; 160(4):258-66.

PMID: 22683412 PMC: 3440512. DOI: 10.1016/j.trsl.2012.02.005.

References
1.
Harris J, De Groote M, Sagel S, Zemanick E, Kapsner R, Penvari C . Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A. 2007; 104(51):20529-33. PMC: 2154465. DOI: 10.1073/pnas.0709804104. View

2.
Hartmann M, Frey B, Kolliker R, Widmer F . Semi-automated genetic analyses of soil microbial communities: comparison of T-RFLP and RISA based on descriptive and discriminative statistical approaches. J Microbiol Methods. 2005; 61(3):349-60. DOI: 10.1016/j.mimet.2004.12.011. View

3.
Shade A, Jones S, McMahon K . The influence of habitat heterogeneity on freshwater bacterial community composition and dynamics. Environ Microbiol. 2008; 10(4):1057-67. DOI: 10.1111/j.1462-2920.2007.01527.x. View

4.
Ward D, Weller R, Bateson M . 16S rRNA sequences reveal uncultured inhabitants of a well-studied thermal community. FEMS Microbiol Rev. 1990; 6(2-3):105-15. DOI: 10.1111/j.1574-6968.1990.tb04088.x. View

5.
Hughes D, Russell N . The use of trimethoprim-sulfamethoxazole in the treatment of chest infections. Rev Infect Dis. 1982; 4(2):528-32. DOI: 10.1093/clinids/4.2.528. View